Prevention of Complications of Eye Surgery
Launched by ISFAHAN UNIVERSITY OF MEDICAL SCIENCES · May 24, 2007
Trial Information
Current as of June 21, 2025
Completed
Keywords
ClinConnect Summary
Objectives: Despite various proposed maneuver, successfully predicting an oculocardiac reflex (OCR) is difficult to achieve. This study was designed to investigate pre-operatively measured parameters of various anaesthetic regimes, iris color, sex, age, surgical time, severity of Marcus-Gunn Pupil (MGP), type of mechanical stimulation of eye, and number of extraocular muscle (EOM) under tension as predictors of significant OCR in pediatric strabismus surgery.
Methods: Three hundred patients were randomized to one of three anesthetic regimes: group P: propofol (2 mg/kg), alfentanil 0.02 mg/...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 300 ASA physical status I or II patients, aged 2-18 years, who candidate for elective strabismus surgery
- Exclusion Criteria:
- • trauma to eye, ASA III or IV, who had contraindication for using thiopental, ketamine, or propofol, had cardiovascular diseases or had taken cardiovascular drugs
About Isfahan University Of Medical Sciences
Isfahan University of Medical Sciences is a leading academic institution in Iran, dedicated to advancing healthcare through innovative research and education. With a strong emphasis on clinical trials, the university plays a critical role in developing new medical treatments and improving patient outcomes. Its research initiatives are supported by a diverse team of professionals, including physicians, scientists, and healthcare practitioners, who collaborate to address pressing health challenges. The university is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its clinical research endeavors. Through its comprehensive approach, Isfahan University of Medical Sciences aims to contribute significantly to the global medical community and enhance public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tehran, Isfahan, Iran, Islamic Republic Of
Patients applied
Trial Officials
mohammad safavi, phd
Study Chair
isfahan committee of research
hasan soltani, phd
Principal Investigator
feiz hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials